Intersect ent, inc. (XENT)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Revenue

19,826

31,754

24,056

26,659

26,673

32,783

24,666

26,300

24,723

29,529

22,313

23,985

20,474

24,231

18,468

19,317

16,692

18,791

14,232

15,198

13,372

13,425

9,100

8,565

7,497

6,972

4,279

3,936

2,744

Cost of sales

6,410

7,206

4,876

5,046

4,645

6,371

5,202

5,558

5,482

5,123

3,808

3,684

2,884

3,888

2,788

3,117

3,210

3,715

2,877

2,904

2,792

2,967

2,576

2,320

2,360

2,561

1,438

2,202

1,949

Gross profit

13,416

24,548

19,180

21,613

22,028

26,412

19,464

20,742

19,241

24,406

18,505

20,301

17,590

20,343

15,680

16,200

13,482

15,076

11,355

12,294

10,580

10,458

6,524

6,245

5,137

4,411

2,841

1,734

795

Operating expenses:
Selling, general and administrative

26,200

27,233

26,429

27,611

27,207

26,322

22,760

21,005

21,516

22,298

18,746

18,682

20,319

19,833

17,905

17,795

17,393

16,480

16,420

14,117

12,620

11,495

9,667

8,291

6,658

6,092

4,700

4,087

3,350

Research and development

5,146

5,831

6,145

6,041

6,266

5,743

4,872

4,374

4,273

5,618

4,346

4,176

4,220

5,570

4,237

4,588

4,495

4,445

4,799

4,038

3,326

2,619

2,758

2,377

2,577

2,764

2,077

2,421

2,256

Total operating expenses

31,346

33,064

32,574

33,652

33,473

32,065

27,632

25,379

25,789

27,916

23,092

22,858

24,539

25,403

22,142

22,383

21,888

20,925

21,219

18,155

15,946

14,114

12,425

10,668

9,235

8,856

6,777

6,508

5,606

Loss from operations

-17,930

-8,516

-13,394

-12,039

-11,445

-5,653

-8,168

-4,637

-6,548

-3,510

-4,587

-2,557

-6,949

-5,060

-6,462

-6,183

-8,406

-5,849

-9,864

-5,861

-5,366

-3,656

-5,901

-4,423

-4,098

-4,445

-3,936

-4,774

-4,811

Interest income and other, net

397

559

546

655

640

623

572

477

412

358

326

288

268

244

236

224

185

104

126

48

28

-

-

-

-

-

-

-

-

Net loss

-17,533

-7,957

-12,848

-11,384

-10,805

-5,030

-7,596

-4,160

-6,136

-3,152

-4,261

-2,269

-6,681

-4,816

-6,226

-5,959

-8,221

-5,745

-9,738

-5,813

-5,338

-3,686

-5,885

-4,382

-4,409

-4,632

-4,099

-4,885

-4,753

Other comprehensive income (loss):
Unrealized (loss) gain on short-term investments, net

-19

-41

-3

61

77

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-17,552

-7,998

-12,851

-11,323

-10,728

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share, basic and diluted

-0.54

-0.25

-0.41

-0.36

-0.35

-0.16

-0.25

-0.14

-0.21

-0.11

-0.15

-0.08

-0.23

-0.17

-0.22

-0.21

-0.29

-0.20

-0.35

-0.23

-0.23

-0.16

-0.32

-2.36

-2.49

-2.64

-2.39

-3.69

-4.57

Weighted average common shares used to compute net loss per share, basic and diluted

32,365

31,778

31,483

31,362

30,918

30,624

30,475

30,264

29,878

29,538

29,269

28,950

28,708

28,610

28,479

28,379

28,207

28,084

27,979

25,015

23,488

23,375

18,217

1,860

1,773

1,755

1,718

1,323

1,039